PerMedCoE, which stands for the HPC/Exascale Center of Excellence in Personalized Medicine, is a European Center of Excellence for providing AI to assist with personalized medicine. The project aims to take full advantage of the power of supercomputers active across Europe to optimize the analysis of biological and medical data from patients and offer them a […]
Latest release of first-in-class enterprise software solution automates the data flow in translational and exploratory clinical research from data ingestion to reporting Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of a new version of Genedata Profiler®, the innovative platform for translational and exploratory clinical […]
New England Journal of Medicine publication showcases technology-driven variant detection platforms in accurately identifying causative genetic mutations OAKLAND, Calif. — The New England Journal of Medicine has published findings from a pilot study that has shown how whole genome sequencing (WGS) uncovered new diagnoses for patients across the broadest range of rare diseases. The identification and prioritization […]
Genomenon to Make Variant Data on ENPP1 Deficiency Available to Genetic Testing Labs Across the World Ann Arbor, Michigan – Genomenon, Inc. ® , an AI-driven genomics company, announced a partnership with Inozyme Pharma to make critical information readily accessible to genetic testing labs and clinicians. This information will help inform diagnosis and thus treatment […]
NEW YORK — Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd. (Geneyx), an Israel-based developer of genomic analysis and interpretation software. Geneyx helps improve patient outcomes associated with hereditary and rare diseases by providing disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations. Today, […]
Qlucore AB (public) (“Qlucore” or “Company”) has today received approval of the application for listing of Qlucore shares on the Nasdaq First North Growth Market. The first day of trading of the shares will be 5th November 2021. Trading will be done with the ticker QCORE. “This paves the way for a new phase in […]
Funds to drive commercial expansion as growing number of facilities bring genomics into communities worldwide ST. LOUIS, MO — PierianDx, the global leader in clinical genomics knowledge, announced that it closed on $30 million of new growth capital including equity financing and a term loan facility, which includes access to additional tranches for up to […]
Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology
– Enabling solutions for biopharmaceutical development and production – Tokyo, Japan – Yokogawa Electric Corporation (TOKYO: 6841) announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess software and services. Fostering the development of the bioeconomy is one of the priority issues within Yokogawa’s sustainability goals, […]
New bioinformatic workflow advances analysis capabilities for whole exome assessment and interpretation BOSTON and LAUSANNE, Switzerland — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today they have extended their SOPHiA DDM™ Universal Whole Exome analytical capabilities to include industry leading exome SureSelect Human All […]
The new biological pathway focus, paired with a proprietary pathway visualization tool, gives users a new way to interpret the metabolome. MORRISVILLE, N.C. – As part of its continued commitment to developing innovative tools and solutions that advance the understanding of human health and the life sciences, Metabolon, Inc., has launched the first offering from its new SmartPanel™ […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
